Moderna Stock Latest News

The regulators might be uncertain whether Moderna’s (MRNA) Covid-19 vaccine is suitable for younger people, but an FDA...

Pfizer is still a good buy as it’s a solid company with a dividend track record. Moderna is...

Shares of Moderna, Inc. (MRNA) declined 9% to close at $302.42 on Wednesday after Swedish and Danish health...

Further validating Moderna’s (MRNA) already highly successful Covid-19 vaccine program, on Tuesday the company announced that the European...

Shares of Moderna, Inc. (MRNA) rose 1.9% to close at $332.11 on Tuesday after the biotechnology company received...

Moderna (MRNA) makes a strong case to be known as one of the top innovators on the planet....

The record rally in Moderna (MRNA) stock has hit a pause as rivals Merck & Company (MRK) and...

Biotechnology company Moderna, Inc. (MRNA) recently announced that it will invest and establish a new science center, the...

Pharmaceutical and biotechnology company Moderna, Inc (MRNA) recently announced that it has signed a supply agreement with the government...

Health Canada has approved Massachusetts-based clinical-stage biotechnology firm Moderna’s (MRNA) New Drug Submission (NDS-CV) for Spikevax, also known...

Biotech firm Moderna (MRNA) has been one of the key players in combating COVID-19, becoming of the earliest...

There’s no stopping the Moderna (MRNA) juggernaut. Shares are up by 330% year-to-date, with the latest uptick following...

Moderna (MRNA) has become one of the hottest stocks in the pharma/biotech world, thanks to its success with...

The COVID-19 pandemic has seen its presence linger, with increased viral circulation causing mutations and variants to spring...

BioNtech (BNTX) and Pfizer (PFE) received full FDA approval of their COVID-19 vaccine in August. Moderna (MRNA) is...

Moderna, Inc. (MRNA) revealed that it has submitted data to the European Medicines Agency (EMA) for conditional marketing...

Pharmaceutical leader Moderna (MRNA) was on top of the world, for a minute there. One of the only...

According to a report published by Reuters, Massachusetts-based pharmaceutical and biotechnology firm Moderna (MRNA) has put the supply...

Once the COVID-19 pandemic became a reality, several firms began racing to produce the most rapid and effective...

The stock market is often a vehicle for storytelling. That is, sentiment around a particular company can be...

Massachusetts-based biotechnology firm Moderna (MRNA) has reported outstanding financial results for the second quarter of 2021. The company...

Moderna (MRNA) is scheduled to report second-quarter 2021 earnings on August 5, before the market open. Moderna is...

Moderna (MRNA) is one of those names that received a great deal of public attention due to the virus...

Vaccine maker Moderna, Inc. (MRNA) announced that it has procured a supply order for an additional 50 million...

If you had to choose an all-out success story of the Covid era, Moderna (MRNA) would be high...

Pharmaceutical behemoth Moderna (MRNA) announced on Thursday that it is set to join the S&P 500 from July...

The COVID-19 pandemic resulted in a race to develop effective vaccines for the virus. This also brought to...

Biotechnology company Moderna (MRNA) revealed that patient dosing has begun in its Phase 1/2 study of quadrivalent seasonal...

The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines...

Vaccine maker Moderna, Inc. (MRNA) announced that in vitro studies showed Moderna’s COVID-19 vaccines are effective against emerging...

U.S. stock futures jumped on Wednesday as investors await the first-quarter current account report, to be released today....

Moderna, Inc. (MRNA), known for its messenger RNA (mRNA) therapeutics and vaccines, confirmed the purchase of 150 million...

Moderna (MRNA) plans to increase its COVID-19 vaccine production capacity to meet the growing demand for doses, according...

U.S. stock futures were trending higher on Tuesday ahead of the Federal Open Market Committee (FOMC) two-day policy...

The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has submitted an application to Swissmedic for the authorized use...

U.S. stock futures were mixed on Monday as S&P 500 recorded an all-time high at the end of...

The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine...

Notwithstanding the horrors of the novel coronavirus pandemic, one definitive bright spot that emerged is the rapid-fire development...

U.S. stock futures trended higher on Friday as investors await the University of Michigan’s consumer sentiment numbers for...

Pharmaceutical and biotechnology company Moderna (MRNA) has filed an application with the U.S. Food and Drug Administration to...

The shares of the pharmaceutical and biotechnology company, Moderna Inc. (MRNA), rose 6.6% to $219.57 on June 7...

Biotechnology company Moderna Inc. (MRNA) has inked an additional drug substance manufacturing agreement with Lonza. Per the terms...

Shares of Moderna Inc. (MRNA) jumped 3.1% to close at $169.26 on May 25 after the company announced...

Moderna, Inc. (MRNA) is expanding its partnership with Aldevron, LLC to support the biotech company’s COVID-19 vaccine and...

Shares of Moderna Inc. (MRNA) declined 2.7% to close at $161.45 on May 21 after the biotech company...

Moderna, Inc. (MRNA) has won a new order for the supply of 25 million doses of its COVID-19...

Moderna’s (MRNA) opportunity to halt the spread of Covid-19 made the biotech company one of 2020’s star performers....

Moderna (MRNA) reported better-than-expected 1Q earnings and the first profitable quarter in its history. Meanwhile, revenues for the...

Shares of Moderna Inc. (MRNA) spiked 4% to close at $186.02 on May 3 after the company revealed...

Moderna Inc. (MRNA) revealed its plan of investments to accelerate the supply of its COVID-19 vaccine at its...